Blood eosinophil-guided therapy for COPD exacerbations

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

(2023) Alvar Agustí et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study

(2023) Simiao Chen et al.   Lancet Global Health

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial

(2023) Sanjay Ramakrishnan et al.   Lancet Respiratory Medicine

The effect of exacerbation history on outcomes in the IMPACT trial

(2020) David M.G. Halpin et al.   EUROPEAN RESPIRATORY JOURNAL

Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial

(2019) Pradeesh Sivapalan et al.   Lancet Respiratory Medicine

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials

(2018) Mona Bafadhel et al.   Lancet Respiratory Medicine

Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis

(2016) Ian D Pavord et al.   Lancet Respiratory Medicine

Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease

(2012) Mona Bafadhel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Acute Exacerbations of Chronic Obstructive Pulmonary Disease

(2011) Mona Bafadhel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE